These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas. Fan X; Wang Y; Liu Y; Liu X; Zhang C; Wang L; Li S; Ma J; Jiang T J Neurooncol; 2016 Jul; 128(3):455-62. PubMed ID: 27230769 [TBL] [Abstract][Full Text] [Related]
5. TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas. Simon M; Hosen I; Gousias K; Rachakonda S; Heidenreich B; Gessi M; Schramm J; Hemminki K; Waha A; Kumar R Neuro Oncol; 2015 Jan; 17(1):45-52. PubMed ID: 25140036 [TBL] [Abstract][Full Text] [Related]
6. Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population. Saadeh FS; Morsi RZ; El-Kurdi A; Nemer G; Mahfouz R; Charafeddine M; Khoury J; Najjar MW; Khoueiry P; Assi HI PLoS One; 2020; 15(11):e0242793. PubMed ID: 33237934 [TBL] [Abstract][Full Text] [Related]
7. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity. Nakajima N; Nobusawa S; Nakata S; Nakada M; Yamazaki T; Matsumura N; Harada K; Matsuda H; Funata N; Nagai S; Nakamura H; Sasaki A; Akimoto J; Hirato J; Yokoo H Brain Pathol; 2018 Sep; 28(5):663-673. PubMed ID: 29105198 [TBL] [Abstract][Full Text] [Related]
8. Beyond the exome: the role of non-coding somatic mutations in cancer. Piraino SW; Furney SJ Ann Oncol; 2016 Feb; 27(2):240-8. PubMed ID: 26598542 [TBL] [Abstract][Full Text] [Related]
10. TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma. Mosrati MA; Malmström A; Lysiak M; Krysztofiak A; Hallbeck M; Milos P; Hallbeck AL; Bratthäll C; Strandéus M; Stenmark-Askmalm M; Söderkvist P Oncotarget; 2015 Jun; 6(18):16663-73. PubMed ID: 26143636 [TBL] [Abstract][Full Text] [Related]
11. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Han L; Zhang K; Shi Z; Zhang J; Zhu J; Zhu S; Zhang A; Jia Z; Wang G; Yu S; Pu P; Dong L; Kang C Int J Oncol; 2012 Jun; 40(6):2004-12. PubMed ID: 22446686 [TBL] [Abstract][Full Text] [Related]
12. Short non-coding RNA sequencing of glioblastoma extracellular vesicles. de Mooij T; Peterson TE; Evans J; McCutcheon B; Parney IF J Neurooncol; 2020 Jan; 146(2):253-263. PubMed ID: 31912278 [TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma. Neubauer HA; Tea MN; Zebol JR; Gliddon BL; Stefanidis C; Moretti PAB; Pitman MR; Costabile M; Kular J; Stringer BW; Day BW; Samuel MS; Bonder CS; Powell JA; Pitson SM Oncogene; 2019 Feb; 38(8):1151-1165. PubMed ID: 30250299 [TBL] [Abstract][Full Text] [Related]
15. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes. Sintupisut N; Liu PL; Yeang CH Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387 [TBL] [Abstract][Full Text] [Related]
16. Whole-exome sequencing revealed mutational profiles of giant cell glioblastomas. Shi ZF; Li KK; Kwan JSH; Yang RR; Aibaidula A; Tang Q; Bao Y; Mao Y; Chen H; Ng HK Brain Pathol; 2019 Nov; 29(6):782-792. PubMed ID: 30861589 [TBL] [Abstract][Full Text] [Related]
17. Assessment of ctDNA in CSF may be a more rapid means of assessing surgical outcomes than plasma ctDNA in glioblastoma. Li JH; He ZQ; Lin FH; Chen ZH; Yang SY; Duan H; Jiang XB; Al-Nahari F; Zhang XH; Wang JH; Zhang GH; Zhang ZF; Li C; Mou YG Mol Cell Probes; 2019 Aug; 46():101411. PubMed ID: 31173881 [TBL] [Abstract][Full Text] [Related]
18. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray. Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819 [TBL] [Abstract][Full Text] [Related]
19. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method. Kunkle B; Yoo C; Roy D Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424 [TBL] [Abstract][Full Text] [Related]
20. Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome. Favero F; McGranahan N; Salm M; Birkbak NJ; Sanborn JZ; Benz SC; Becq J; Peden JF; Kingsbury Z; Grocok RJ; Humphray S; Bentley D; Spencer-Dene B; Gutteridge A; Brada M; Roger S; Dietrich PY; Forshew T; Gerlinger M; Rowan A; Stamp G; Eklund AC; Szallasi Z; Swanton C Ann Oncol; 2015 May; 26(5):880-887. PubMed ID: 25732040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]